United States

People: Orthofix International NV (OFIX.OQ)

OFIX.OQ on NASDAQ Stock Exchange Global Select Market

21 Jul 2017
Change (% chg)

$-0.35 (-0.76%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Finegan, Michael 

Mr. Michael M. Finegan is Chief Strategy Officer of Orthofix International N.V., effective June 20, 2013. Mr. Finegan joined Orthofix International N.V. in June 2006 as Vice President of Corporate Development, and became the President, Biologics in March 2009. In October 2011, he was promoted to Senior Vice President, Business Development, and President, Biologics, and in June 2013, to his current position as Chief Strategy Officer. Prior to joining Orthofix, Mr. Finegan spent sixteen years as an executive with Boston Scientific in a number of different operating and strategic roles, most recently as Vice President of Corporate Sales. Earlier in his career, Mr. Finegan held sales and marketing roles with Marion Laboratories and spent three years in banking with First Union Corporation (Wachovia). Mr. Finegan earned a BA in Economics from Wake Forest University.

Basic Compensation

Total Annual Compensation, USD 814,002
Restricted Stock Awards, USD 402,375
Long-Term Incentive Plans, USD --
All Other, USD 150,887
Fiscal Year Total, USD 1,367,260

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ronald Matricaria


Bradley Mason


Doug Rice


Davide Bianchi


Michael Finegan


Luke Faulstick

As Of  30 Dec 2014